Thermo Fisher Scientific (NYSE:TMO) has obtained all antitrust clearancesfor its previously announced acquisition of Patheon N.V., including the European Commission who blessed the deal today.
The company plans to finalize the transaction within a week.
Previously: Pantheon up 33% premarket on $7.2B Thermo Fisher bid (May 15)
READ FULL ARTICLE HERE